• Citer

HER-2/neu evaluation by immunohistochemistry and fluorescence in situ hybridization in breast cancer: implications for daily laboratory practice.

par Larsimont, Denis ;Di Leo, Angelo ;Rouas, Ghizlane;Paesmans, Marianne ;Ferreira Filho, Antonio Fabiano ;Bernard, Chantal ;Cardoso, Fatima ;Verhest, Alain;Piccart-Gebhart, Martine ;Gancberg, David
Référence Anticancer research, 22, 4, page (2485-2490)
Publication Publié, 2002

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	HER-2/neu evaluation by immunohistochemistry and fluorescence in situ hybridization in breast cancer: implications for daily laboratory practice.
Auteur:	Larsimont, Denis; Di Leo, Angelo; Rouas, Ghizlane; Paesmans, Marianne; Ferreira Filho, Antonio Fabiano; Bernard, Chantal; Cardoso, Fatima; Verhest, Alain; Piccart-Gebhart, Martine; Gancberg, David
Informations sur la publication:	Anticancer research, 22, 4, page (2485-2490)
Statut de publication:	Publié, 2002
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Antibodies, Monoclonal
	Breast Neoplasms -- genetics
	Breast Neoplasms -- pathology
	Female
	Humans
	Immunohistochemistry
	In Situ Hybridization, Fluorescence
	Laboratories -- standards
	Receptor, erbB-2 -- analysis
	Receptor, erbB-2 -- genetics
	Reproducibility of Results
Note générale:	Comparative Study
	Journal Article
	Multicenter Study
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:0250-7005
	info:scp/0036339443
	info:pmid/12174949
	VX-005565